Baylor College of Medicine

A trial to evaluate Tavapadon for Parkinson's disease in Levodopa treatment adults with motor fluctuations (H-48193)



A 27 Week Phase 3, Double-blind, Placebo-controlled Trial to evaluate Tavapadon for PD in Levodopa treatment adults with motor fluctuations.  Open extension study to follow. 

If you or a loved one have been diagnosed with Parkinson's disease (PD), you or your loved one may be interested in participating in one of the TemPo Studies.  They are a suite of three clinical research studies evaluating an oral investigational drug (tavapadon) to see if it may help improve PD symptoms that impact your movement and daily activities. 

You may be eligible to participate if you meet the following eligibility criteria:

  • have been diagnosed with PD
  • are 40 to 80 years of age
  • have never received deep brain stimulation treatment.


Rory Mahabir

Phone 1: 713–798–5989

IRB: H-48193




Back to topback-to-top